13 February 2017
The Age | Researchers raise concerns over sexually transmitted superbug
This drug-resistant sexually transmitted infection is behaving like a superbug and researchers estimate as many as 400,000 Australians may be...
2 February 2017
Evaluation of SpeeDx PlexPrime® and PlexZyme® technology published in PLOS One
SpeeDx Pty. Ltd. announced the publication of a novel technology, ‘Superior Multiplexing Capacity of PlexPrimers Enables Sensitive and Specific Detection...
17 January 2017
SpeeDx Receives TGA Approval For ResistancePlus MG
Mycoplasma genitalium (MG) is one of the fastest growing STIs in the world and has been reported to have a...
11 January 2017
Evaluation of SpeeDx’s CE-marked ResistancePlus MG test for M. genitalium published in Journal of Clinical Microbiology
ResistancePlus® MG rapidly and reliably detects the disease and determines antibiotic resistance of this increasingly resistant sexually transmitted infection. SpeeDx Pty....
21 November 2016
Antibiotic Guardian Campaign aims to raise awareness of Antibiotic Resistance in STI’s
Dr Jensen’s article highlights the problem facing us but provides a guide to potential solutions. Dr Jorgen Jensen has contributed an...
18 November 2016
SpeeDx at Australasian Sexual Health Conference 2016: The Review
SpeeDx present recent findings on theResistancePlus® MG test at the 2016 Australasian Sexual Health Conference. SpeeDx R&D Director Dr Litty Tan...